Professor Arjen Dondorp
The treatment of severe malaria
Successful malaria control has meant a drop in mortality rates worldwide but it is still an important disease. Therapies using artesunate, a derivative of artemisinin drugs, aim to kill malaria parasites before they mature. These therapies have high success rates and need to be developed. General care of malaria patients also needs to be improved.
Professor of Tropical Medicine
- Deputy Director of the Mahidol Oxford Clinical Research Unit, Thailand
I am an intensive care and infectious diseases physician and trained in the Netherlands. Since 2001 I work at the Mahidol-Oxford Tropical Medicine Research Unit in Bangkok, Thailand where I am currently the Deputy Director and Head of the Malaria and Critical Illness Department. I am a Professor of Tropical Diseases at Oxford University, and a visiting Professor at the Mahidol University in Bangkok, Thailand.
My main research interests include the pathophysiology and treatment of severe malaria, antimalarial drug resistance, new treatments for drug resistant falciparum malaria and the improvement of intensive care practice in developing countries. In addition to my work at MORU, I currently chair the Regional Steering Committee for the Regional Artemisinin-resistance Initiative from the Global Fund. This is a large regional grant supporting the malaria elimination efforts in the Greater Mekong Subregion of Southeast Asia.
van der Pluijm RW. et al, (2021), Lancet (London, England), 396, 1976 - 1977
Choisy M. et al, (2021)
Hamaluba M. et al, (2021), The Lancet. Infectious diseases, 21, 1395 - 1406
Pisani L. et al, (2021), Wellcome Open Research, 6, 251 - 251
de Haan F. et al, (2021), Environmental Innovation and Societal Transitions, 40, 40 - 59